Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
95
Number of overlapping holdings
80.5%
% of XBI's 119 holdings also in IBBQ
43.2%
% of IBBQ's 220 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.8% | 3.6% | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.5% | 8.5% | 2.5% |
|
AMGEN INC | 2.4% | 8.2% | 2.4% |
|
GILEAD SCIENCES INC | 2.4% | 8.1% | 2.4% |
|
REGENERON PHARMACEUTICALS | 2.3% | 7.1% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IBBQ
|
NATERA INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
EXACT SCIENCES CORP | 2.3% |
|
TG THERAPEUTICS INC | 1.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.5% |
|
BLUEPRINT MEDICINES CORP. | 1.4% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% |
|
VAXCYTE, INC. | 1.2% |
|
INSMED INC | 1.2% |
|
VIKING THERAPEUTICS, INC. | 1.1% |
XBI Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -6.0% |
|
AMGEN INC | -5.8% |
|
GILEAD SCIENCES INC | -5.7% |
|
REGENERON PHARMACEUTICALS | -4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.4% |
 |
ARGENX SE ADR | -1.9% |
 |
SANOFI-AVENTIS-ADR | -1.7% |
|
INTRA-CELLULAR THERAPIES INC | -1.4% |
|
ROYALTY PHARMA PLC CLASS A | -1.4% |
|
ILLUMINA INC | -1.3% |